The Fentanyl Citrate Injection, cataloged under National Stock Number 6505-01-696-3087, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hospira Worldwide Llc. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-696-3087 |
| Primary Part Number | NDC00409-9094-31 |
| Item Name | Fentanyl Citrate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hospira Worldwide Llc |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE II |
| Primary Container Content Quantity | 20.0 MILLILITERS |
| Secondary Container Type | PACKAGE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL, SINGLE DOSE |
| Active Medicament Medicinal Strength | 50.0 MICROGRAMS FENTANYL CITRATE PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00409-9094-31 PRIMARY | Hospira Worldwide Llc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM217240 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1599102 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-696-3087 is a Fentanyl Citrate Injection, manufactured by Hospira Worldwide Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-696-3087 has 1 manufacturer part number on file: NDC00409-9094-31 (Hospira Worldwide Llc).
Key specifications for NDC00409-9094-31: Controlled Substance Classification: SCHEDULE II; Primary Container Content Quantity: 20.0 MILLILITERS; Secondary Container Type: PACKAGE; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.